Laurion Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60,400	Closed	-$353K	–	447
2024 Q2	$353K	Sell	60,400 -302,084	-83%	-$1.77M	﹤0.01%	284
2024 Q1	$2.88M	Buy	362,484 +302,084	+500%	+$2.4M	0.02%	153
2023 Q4	$352K	Buy	+60,400	New	+$352K	﹤0.01%	202